Research Article

The Positive and Negative Effects of Calcium Supplementation on Mortality in Septic ICU Patients Depend on Disease Severity: A Retrospective Study from the MIMIC-III

Table 4

The clinical characteristics of septic patients with or without calcium supplementation (before and after propensity score matching).

Clinical parametersBefore propensity score matchingAfter propensity score matching
Calcium supplementation (n = 2,689)Nonsupplementation (n = 3,072) valueCalcium supplementation (n = 993)Nonsupplementation (n = 993) value

Age (years; median, Q1∼Q3)64.85 (52.01∼77.82)68.77 (55.95∼81.51)<0.00166.91 (53.49∼79.96)67.14 (55.56∼79.58)0.553
Sex (male, %)1541 (57.31)1672 (54.43)0.013541 (54.48%)529 (53.27%)0.589

Complications (n, %)
Cardiac arrhythmias988 (36.74%)1124 (36.6%)0.911347 (34.94%)364 (36.66%)0.426
Liver disease470 (17.48%)437 (14.23%)0.001152 (15.31%)154 (15.51%)0.901
Renal failure491 (18.26%)647 (21.07%)0.008187 (18.83%)194 (19.54%)0.690
Fluid electrolyte1392 (51.77%)1304 (42.46%)<0.001497 (50.05%)480 (48.34%)0.445
Metastatic cancer166 (6.17%)229 (7.46%)0.05476 (7.65%)81 (8.16%)0.678

Severity
Lactate at the first hospital admission (median, Q1∼Q3)1.90 (1.30∼3.10)1.70 (1.2∼2.5)<0.0011.8 (1.2∼2.6)1.8 (1.2∼2.6)0.474
Septic_shock_explicit (n, %)472 (17.55%)266 (8.66%)<0.001142 (14.3%)135 (13.6%)0.650
Vent (n, %)1659 (61.7%)1120 (36.46%)<0.001466 (46.93%)477 (48.04%)0.621
SOFA (mean ± SD)6.05 ± 3.6114.85 ± 2.71<0.0015.40 ± 2.925.40 ± 2.900.939
28-day mortality (n, %)442 (16.43)352 (11.46%)0.005134 (13.49%)142 (14.30%)0.818
Hospital mortality (n, %)471 (17.52)361 (11.75%)<0.001144 (14.5%)145 (14.6%)0.949
ICU LOS (days; median, Q1∼Q3)3.65 (1.87∼7.97)2.01 (1.12∼3.64)<0.0013.04 (1.83∼6.93)2.11 (1.24∼3.95)<0.001
Hospital LOS (days; median, Q1∼Q3)8.99 (5.54∼15.67)6.57 (3.84∼10.59)<0.0018.26 (5.37∼14.11)6.87 (4.11∼10.88)<0.001

SOFA, sequential organ failure assessment; qSOFA, quick sequential organ failure assessment; ICU LOS, intensive care unit length of stay; hospital LOS, hospital length of stay.